▶ Manufacturer: Ilhwa Co., Ltd.
▶ Sold by: Ilhwa Co., Ltd.
▶ Insurance code : A06502391
▶ Storage : Sealed container, store at room temperature (1 to 30℃)
White to off-white egg-shaped film-coated tablet
Itraconazole 100mg
ㆍFor improved absorption, this drug should be administered immediately after meals.
1. Short-term administration
This drug exhibits sustained therapeutic effects in skin tissue even after discontinuation of administration. Accordingly, judgment of final clinical and mycological treatment effect should preferably be 2 to 4 months after completion of treatment.
1) Vaginal candidiasis: Administer 200mg itraconazole twice a day (morning, evening) for 1 day, or administer 200mg once a day for 3 days.
2) Leucoderma: Administer 200mg once a day for 7 days.
3) Tinea corporis, tinea cruris: Administer 100mg once a day for 15 days.
4) Tinea manus (interdigital), tinea pedis (interdigital): Administer 100mg once a day for 15 days.
5) Tinea manus (palm), tinea pedis (plantar): Administer 100mg once a day for 30 days or 200mg twice a day for 7 days.
6) Oral candidiasis: Administer 100mg once a day for 15 days.
7) Fungal keratitis: Administer 200mg once a day for 21 days.
2. Onychomycosis
1) Periodic therapy
Administer 200mg twice daily for 1 week and discontinue for 3 weeks for 1 cycle. Administer for 2 cycles for fingernail infection, and administer for 3 cycles for toenail infection.
2) Sequential therapy
Administer 200mg once a day for 3 months. Therapeutic effect is sustained for 3 months after discontinuation for fingernails, and 6 months for toenails.
3. Systemic mycoses
Oral bioavailability of this drug may be reduced in the case of immunosuppressed patients with neutropenia, AIDS, or organ transplants. Double administration dose if necessary.
1. Candida vaginitis
2. Leucoderma
3. Tinea corporis, tinea cruris, tinea manus, or tinea pedis due to dermatophytes
4. Oral candidiasis
5. Fungal keratitis
6. Onychomycosis
7. The following systemic fungal infections : aspergillosis, candidiasis, cryptococcosis (including cryptococcal meningitis), paracoccidioidomycosis
White to off-white egg-shaped film-coated tablet
Itraconazole 100mg
ㆍFor improved absorption, this drug should be administered immediately after meals.
1. Short-term administration
This drug exhibits sustained therapeutic effects in skin tissue even after discontinuation of administration. Accordingly, judgment of final clinical and mycological treatment effect should preferably be 2 to 4 months after completion of treatment.
1) Vaginal candidiasis: Administer 200mg itraconazole twice a day (morning, evening) for 1 day, or administer 200mg once a day for 3 days.
2) Leucoderma: Administer 200mg once a day for 7 days.
3) Tinea corporis, tinea cruris: Administer 100mg once a day for 15 days.
4) Tinea manus (interdigital), tinea pedis (interdigital): Administer 100mg once a day for 15 days.
5) Tinea manus (palm), tinea pedis (plantar): Administer 100mg once a day for 30 days or 200mg twice a day for 7 days.
6) Oral candidiasis: Administer 100mg once a day for 15 days.
7) Fungal keratitis: Administer 200mg once a day for 21 days.
2. Onychomycosis
1) Periodic therapy
Administer 200mg twice daily for 1 week and discontinue for 3 weeks for 1 cycle. Administer for 2 cycles for fingernail infection, and administer for 3 cycles for toenail infection.
2) Sequential therapy
Administer 200mg once a day for 3 months. Therapeutic effect is sustained for 3 months after discontinuation for fingernails, and 6 months for toenails.
3. Systemic mycoses
Oral bioavailability of this drug may be reduced in the case of immunosuppressed patients with neutropenia, AIDS, or organ transplants. Double administration dose if necessary.
1. Candida vaginitis
2. Leucoderma
3. Tinea corporis, tinea cruris, tinea manus, or tinea pedis due to dermatophytes
4. Oral candidiasis
5. Fungal keratitis
6. Onychomycosis
7. The following systemic fungal infections : aspergillosis, candidiasis, cryptococcosis (including cryptococcal meningitis), paracoccidioidomycosis
